Numida meleagris isolate 19003 breed g44 Domestic line chromosome 12, NumMel1.0, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Numididae; Numida.
REFSEQ INFORMATION: The reference sequence is identical to\nCM007825.2.\nAssembly name: NumMel1.0\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the INRA on 2017/06/01. The\noriginal whole-genome shotgun project has the accession\nMTSP00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: INRA\nAssembly Date :: JUL-2013\nAssembly Method :: AllPaths v. July-2013\nAssembly Name :: NumMel1.0\nReference-guided Assembly :: Gallus_gallus-5.0 (GCF_000002315.4)\nGenome Coverage :: 100.0x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Version :: Numida meleagris Annotation Release\n 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 7.4\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
protocadherin alpha-C2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
protocadherin alpha-C2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histidine--tRNA ligase, cytoplasmic, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
histidine--tRNA ligase, cytoplasmic, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
histidine--tRNA ligase, cytoplasmic, transcript variant X2
histidine--tRNA ligase, cytoplasmic isoform X2
histidine--tRNA ligase, cytoplasmic isoform X3
histidine--tRNA ligase, cytoplasmic isoform X1
DND microRNA-mediated repression inhibitor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DND microRNA-mediated repression inhibitor 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
NADH:ubiquinone oxidoreductase subunit A2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
transmembrane and coiled-coil domains 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
transmembrane and coiled-coil domains 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X2
transmembrane and coiled-coil domains 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
transmembrane and coiled-coil domain-containing protein 6 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable UDP-sugar transporter protein SLC35A4
SLC35A4 upstream open reading frame protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transmembrane protein 173, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transmembrane protein 173, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
transmembrane protein 173, transcript variant X1
transmembrane protein 173, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
stimulator of interferon genes protein isoform X2
stimulator of interferon genes protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CXXC finger protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
CXXC-type zinc finger protein 5 isoform X1
CXXC-type zinc finger protein 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleckstrin and Sec7 domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pleckstrin and Sec7 domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
pleckstrin and Sec7 domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
pro-neuregulin-2, membrane-bound isoform isoform X1
pro-neuregulin-2, membrane-bound isoform isoform X2
uncharacterized LOC110405554, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC110405554, transcript variant X1
uncharacterized LOC110405554, transcript variant X2
uncharacterized LOC110405130, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110405130, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
cysteine rich transmembrane module containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cysteine-rich and transmembrane domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
heparin binding EGF like growth factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
heparin binding EGF like growth factor, transcript variant X1
proheparin-binding EGF-like growth factor isoform X2
proheparin-binding EGF-like growth factor isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and KH domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X3
ankyrin repeat and KH domain-containing protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X6
ankyrin repeat and KH domain-containing protein 1, transcript variant X7
ankyrin repeat and KH domain-containing protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ankyrin repeat and KH domain-containing protein 1 isoform X1
ankyrin repeat and KH domain-containing protein 1 isoform X2
ankyrin repeat and KH domain-containing protein 1 isoform X3
ankyrin repeat and KH domain-containing protein 1 isoform X4
ankyrin repeat and KH domain-containing protein 1 isoform X6
ankyrin repeat and KH domain-containing protein 1 isoform X7
ankyrin repeat and KH domain-containing protein 1 isoform X5
ankyrin repeat and KH domain-containing protein 1 isoform X8
ankyrin repeat and KH domain-containing protein 1 isoform X9
similar to RNA sequence (same species):INSD:GBYG01004260.1
annotated by transcript or proteomic data
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 667 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 324 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
amyloid beta precursor protein binding family B member 3
similar to RNA sequence (same species):INSD:GBYG01016651.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 46 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 46 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
amyloid beta A4 precursor protein-binding family B member 3
protocadherin gamma-C5-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
protocadherin gamma-C5-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 152 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protocadherin gamma-C5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protocadherin gamma-C5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 119 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protocadherin gamma-C5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protocadherin gamma-C5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
histone deacetylase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
histone deacetylase 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01005954.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 109 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 42 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
FCH and double SH3 domains 1, transcript variant X2
FCH and double SH3 domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
F-BAR and double SH3 domains protein 1 isoform X2
F-BAR and double SH3 domains protein 1 isoform X1
FCH and double SH3 domains 1, transcript variant X3
F-BAR and double SH3 domains protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X4
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X3
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 isoform X1
StAR related lipid transfer domain containing 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC110405387, transcript variant X3
uncharacterized LOC110405387, transcript variant X1
uncharacterized LOC110405387, transcript variant X2
uncharacterized LOC110405585, transcript variant X1
uncharacterized LOC110405585, transcript variant X2
uncharacterized LOC110405585, transcript variant X3
uncharacterized LOC110405585, transcript variant X4
uncharacterized LOC110405583, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC110405583, transcript variant X25
uncharacterized LOC110405583, transcript variant X28
uncharacterized LOC110405583, transcript variant X24
uncharacterized LOC110405583, transcript variant X29
uncharacterized LOC110405583, transcript variant X27
uncharacterized LOC110405583, transcript variant X19
uncharacterized LOC110405583, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC110405583, transcript variant X7
uncharacterized LOC110405583, transcript variant X9
uncharacterized LOC110405583, transcript variant X21
uncharacterized LOC110405583, transcript variant X10
uncharacterized LOC110405583, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC110405583, transcript variant X31
uncharacterized LOC110405583, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC110405583, transcript variant X22
uncharacterized LOC110405583, transcript variant X30
uncharacterized LOC110405583, transcript variant X1
uncharacterized LOC110405583, transcript variant X4
uncharacterized LOC110405583, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC110405583, transcript variant X3
uncharacterized LOC110405583, transcript variant X5
uncharacterized LOC110405583, transcript variant X13
uncharacterized LOC110405583, transcript variant X14
uncharacterized LOC110405583, transcript variant X12
uncharacterized LOC110405583, transcript variant X8
uncharacterized LOC110405583, transcript variant X32
uncharacterized LOC110405583, transcript variant X33
uncharacterized LOC110405583, transcript variant X26
uncharacterized LOC110405583, transcript variant X6
uncharacterized LOC110405583, transcript variant X16
uncharacterized LOC110405583, transcript variant X15
uncharacterized LOC110405583, transcript variant X17
KIAA0141 ortholog, transcript variant X2
KIAA0141 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
KIAA0141 ortholog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
KIAA0141 ortholog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
endothelial cell surface expressed chemotaxis and apoptosis regulator, transcript variant X1
endothelial cell-specific chemotaxis regulator isoform X2
endothelial cell-specific chemotaxis regulator isoform X1
DnaJ heat shock protein family (Hsp40) member C18, transcript variant X1
dnaJ homolog subfamily C member 18 isoform X1
DnaJ heat shock protein family (Hsp40) member C18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
dnaJ homolog subfamily C member 18 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
marginal zone B and B1 cell specific protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
marginal zone B- and B1-cell-specific protein
solute carrier family 23 member 1, transcript variant X1
solute carrier family 23 member 1, transcript variant X3
solute carrier family 23 member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
solute carrier family 23 member 1 isoform X1
solute carrier family 23 member 1 isoform X3
solute carrier family 23 member 1 isoform X4
solute carrier family 23 member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
solute carrier family 23 member 1, transcript variant X5
solute carrier family 23 member 1, transcript variant X6
solute carrier family 23 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
solute carrier family 23 member 1 isoform X2
poly(A) binding protein interacting protein 2
similar to RNA sequence (same species):INSD:GBYG01001688.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 117 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
polyadenylate-binding protein-interacting protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
SIL1 nucleotide exchange factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
SIL1 nucleotide exchange factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nucleotide exchange factor SIL1 isoform X1
SIL1 nucleotide exchange factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
nucleotide exchange factor SIL1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
leucine rich repeat transmembrane neuronal 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat transmembrane neuronal protein 2
heat shock protein family A (Hsp70) member 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
eukaryotic translation termination factor 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
eukaryotic peptide chain release factor subunit 1
F-box and WD repeat domain containing 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
F-box and WD repeat domain containing 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
F-box/WD repeat-containing protein 11 isoform X1
F-box/WD repeat-containing protein 11 isoform X2
uncharacterized LOC110405576, transcript variant X2
uncharacterized LOC110405576, transcript variant X1
uncharacterized LOC110405223, transcript variant X6
uncharacterized LOC110405223, transcript variant X5
uncharacterized LOC110405223, transcript variant X2
uncharacterized LOC110405223, transcript variant X8
uncharacterized LOC110405223, transcript variant X1
uncharacterized LOC110405223, transcript variant X16
uncharacterized LOC110405223, transcript variant X25
uncharacterized LOC110405223, transcript variant X19
uncharacterized LOC110405223, transcript variant X22
uncharacterized LOC110405223, transcript variant X26
uncharacterized LOC110405223, transcript variant X24
uncharacterized LOC110405223, transcript variant X13
uncharacterized LOC110405223, transcript variant X21
uncharacterized LOC110405223, transcript variant X20
uncharacterized LOC110405223, transcript variant X27
uncharacterized LOC110405223, transcript variant X9
uncharacterized LOC110405223, transcript variant X18
uncharacterized LOC110405223, transcript variant X10
uncharacterized LOC110405223, transcript variant X7
uncharacterized LOC110405223, transcript variant X4
uncharacterized LOC110405223, transcript variant X14
uncharacterized LOC110405223, transcript variant X15
uncharacterized LOC110405223, transcript variant X3
uncharacterized LOC110405223, transcript variant X17
uncharacterized LOC110405223, transcript variant X11
uncharacterized LOC110405223, transcript variant X12
uncharacterized LOC110405223, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fibroblast growth factor 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC110405122, transcript variant X1
uncharacterized LOC110405122, transcript variant X2
uncharacterized LOC110405122, transcript variant X4
uncharacterized LOC110405122, transcript variant X3
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
kazal-type serine protease inhibitor domain-containing protein 1-like, transcript variant X1
kazal-type serine protease inhibitor domain-containing protein 1-like
gamma-aminobutyric acid type A receptor pi subunit, transcript variant X4
gamma-aminobutyric acid type A receptor pi subunit, transcript variant X3
gamma-aminobutyric acid type A receptor pi subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor pi subunit, transcript variant X2
gamma-aminobutyric acid receptor subunit pi
potassium voltage-gated channel interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
potassium voltage-gated channel interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kv channel-interacting protein 1 isoform X2
Kv channel-interacting protein 1 isoform X3
Kv channel-interacting protein 1 isoform X1
Kv channel-interacting protein 1 isoform X4
potassium calcium-activated channel subfamily M regulatory beta subunit 1
calcium-activated potassium channel subunit beta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
putative uncharacterized protein C5orf58 homolog
uncharacterized LOC110405561, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110405561, transcript variant X1
uncharacterized LOC110405561, transcript variant X6
uncharacterized LOC110405561, transcript variant X3
uncharacterized LOC110405561, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC110405561, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC110405561, transcript variant X7
uncharacterized LOC110405562, transcript variant X1
uncharacterized LOC110405562, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
family with sequence similarity 196 member B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
spindle apparatus coiled-coil protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
spindle apparatus coiled-coil protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
slit guidance ligand 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
slit guidance ligand 3, transcript variant X2
slit guidance ligand 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
pantothenate kinase 3, transcript variant X2
pantothenate kinase 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 7-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 7-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho GTPase-activating protein 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
rho GTPase-activating protein 7-like isoform X1
rho GTPase-activating protein 7-like isoform X2
rho GTPase-activating protein 7-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
WW and C2 domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
WW and C2 domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X10
teneurin transmembrane protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X5
teneurin transmembrane protein 2, transcript variant X4
teneurin transmembrane protein 2, transcript variant X7
teneurin transmembrane protein 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X14
teneurin transmembrane protein 2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
teneurin transmembrane protein 2, transcript variant X16
teneurin transmembrane protein 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC110405248, transcript variant X1
uncharacterized LOC110405248, transcript variant X2
methionine adenosyltransferase 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
methionine adenosyltransferase 2B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
methionine adenosyltransferase 2 subunit beta isoform X2
methionine adenosyltransferase 2 subunit beta isoform X1
uncharacterized LOC110405184, transcript variant X2
uncharacterized LOC110405184, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor gamma2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor gamma2 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit gamma-2 isoform X2
gamma-aminobutyric acid receptor subunit gamma-2 isoform X1
uncharacterized LOC110405524, transcript variant X1
uncharacterized LOC110405524, transcript variant X2
uncharacterized protein LOC110405524 isoform X1
uncharacterized protein LOC110405524 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor alpha1 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit alpha-1
gamma-aminobutyric acid type A receptor alpha6 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor alpha6 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gamma-aminobutyric acid type A receptor alpha6 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit alpha-6 isoform X2
gamma-aminobutyric acid receptor subunit alpha-6 isoform X1
gamma-aminobutyric acid receptor subunit alpha-6 isoform X3
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gamma-aminobutyric acid type A receptor beta2 subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gamma-aminobutyric acid receptor subunit beta-2 isoform X1
gamma-aminobutyric acid receptor subunit beta-2 isoform X2
gamma-aminobutyric acid receptor subunit beta-2 isoform X3
uncharacterized LOC110405444, transcript variant X1
uncharacterized LOC110405444, transcript variant X3
uncharacterized LOC110405444, transcript variant X2
uncharacterized LOC110405140, transcript variant X2
uncharacterized LOC110405140, transcript variant X1
ATPase phospholipid transporting 10B (putative), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase phospholipid transporting 10B (putative), transcript variant X3
ATPase phospholipid transporting 10B (putative), transcript variant X1
probable phospholipid-transporting ATPase VB
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
SLU7 homolog, splicing factor, transcript variant X1
SLU7 homolog, splicing factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
SLU7 homolog, splicing factor, transcript variant X2
pre-mRNA-splicing factor SLU7 isoform X1
pre-mRNA-splicing factor SLU7 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
complement C1q tumor necrosis factor-related protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X3
fatty acid binding protein 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X8
fatty acid binding protein 6, transcript variant X1
fatty acid binding protein 6, transcript variant X4
fatty acid binding protein 6, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X13
fatty acid binding protein 6, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X12
fatty acid binding protein 6, transcript variant X11
fatty acid binding protein 6, transcript variant X14
fatty acid binding protein 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X16
fatty acid binding protein 6, transcript variant X17
fatty acid binding protein 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
fatty acid binding protein 6, transcript variant X9
PWWP domain containing 2A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
PWWP domain containing 2A, transcript variant X2
PWWP domain-containing protein 2A isoform X3
PWWP domain-containing protein 2A isoform X1
PWWP domain-containing protein 2A isoform X2
tetratricopeptide repeat domain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
tetratricopeptide repeat domain 1, transcript variant X1
uncharacterized LOC110405480, transcript variant X1
uncharacterized LOC110405480, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC110405516, transcript variant X1
uncharacterized LOC110405516, transcript variant X7
uncharacterized LOC110405516, transcript variant X5
uncharacterized LOC110405516, transcript variant X3
uncharacterized LOC110405516, transcript variant X4
uncharacterized LOC110405516, transcript variant X2
uncharacterized LOC110405516, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
5-hydroxytryptamine receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X2
5-hydroxytryptamine receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X1
5-hydroxytryptamine receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
5-hydroxytryptamine receptor 4 isoform X3
sulfate transporter-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sulfate transporter-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sulfate transporter-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
solute carrier family 26 member 2, transcript variant X5
solute carrier family 26 member 2, transcript variant X3
solute carrier family 26 member 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X2
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X1
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X1
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X2
E3 ubiquitin/ISG15 ligase TRIM25-like, transcript variant X3
E3 ubiquitin/ISG15 ligase TRIM25-like isoform X3
E3 ubiquitin-protein ligase TRIM62-like, transcript variant X1
E3 ubiquitin-protein ligase TRIM62-like, transcript variant X2
PPARG coactivator 1 beta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
PPARG coactivator 1 beta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
PPARG coactivator 1 beta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
PPARG coactivator 1 beta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X2
peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X1
peroxisome proliferator-activated receptor gamma coactivator 1-beta isoform X3
Rho guanine nucleotide exchange factor 37, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Rho guanine nucleotide exchange factor 37, transcript variant X4
Rho guanine nucleotide exchange factor 37, transcript variant X1
Rho guanine nucleotide exchange factor 37, transcript variant X3
rho guanine nucleotide exchange factor 37 isoform X1
rho guanine nucleotide exchange factor 37 isoform X2
casein kinase 1 alpha 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
casein kinase 1 alpha 1, transcript variant X1
casein kinase 1 alpha 1, transcript variant X3
casein kinase 1 alpha 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
actin filament associated protein 1 like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
actin filament associated protein 1 like 1, transcript variant X1
actin filament associated protein 1 like 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
actin filament-associated protein 1-like 1 isoform X2
actin filament-associated protein 1-like 1 isoform X1
actin filament-associated protein 1-like 1 isoform X3
actin binding LIM protein family member 3, transcript variant X3
actin binding LIM protein family member 3, transcript variant X2
actin binding LIM protein family member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
actin binding LIM protein family member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
actin binding LIM protein family member 3, transcript variant X7
actin binding LIM protein family member 3, transcript variant X6
actin binding LIM protein family member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X4
SH3 domain and tetratricopeptide repeats 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
SH3 domain and tetratricopeptide repeats 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X3
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X1
SH3 domain and tetratricopeptide repeat-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized LOC110405514, transcript variant X1
uncharacterized LOC110405514, transcript variant X2
uncharacterized LOC110405514, transcript variant X3
uncharacterized LOC110405446, transcript variant X2
uncharacterized LOC110405446, transcript variant X1
ubiquitin domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ubiquitin domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin domain-containing protein 2 isoform X1
ubiquitin domain-containing protein 2 isoform X2
serine/threonine kinase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
serine/threonine-protein kinase 10 isoform X1
serine/threonine kinase 10, transcript variant X2
serine/threonine-protein kinase 10 isoform X2
SH3 and PX domains 2B, transcript variant X1
SH3 and PX domains 2B, transcript variant X2
SH3 and PX domains 2B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
SH3 and PX domain-containing protein 2B isoform X1
SH3 and PX domain-containing protein 2B isoform X2
SH3 and PX domain-containing protein 2B isoform X3
neuralized E3 ubiquitin protein ligase 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
neuralized E3 ubiquitin protein ligase 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase NEURL1B isoform X1
E3 ubiquitin-protein ligase NEURL1B isoform X2
E3 ubiquitin-protein ligase NEURL1B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X2
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X2
endoplasmic reticulum-golgi intermediate compartment 1, transcript variant X1
endoplasmic reticulum-Golgi intermediate compartment protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
CREB3 regulatory factor, transcript variant X3
CREB3 regulatory factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
biorientation of chromosomes in cell division 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
biorientation of chromosomes in cell division 1, transcript variant X1
biorientation of chromosomes in cell division 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
biorientation of chromosomes in cell division protein 1
cytoplasmic polyadenylation element binding protein 4
cytoplasmic polyadenylation element-binding protein 4
chromosome 12 C5orf47 homolog, transcript variant X1
chromosome 12 C5orf47 homolog, transcript variant X5
uncharacterized protein C5orf47 homolog isoform X1
chromosome 12 C5orf47 homolog, transcript variant X3
chromosome 12 C5orf47 homolog, transcript variant X4
uncharacterized protein C5orf47 homolog isoform X4
uncharacterized protein C5orf47 homolog isoform X3
chromosome 12 C5orf47 homolog, transcript variant X2
uncharacterized protein C5orf47 homolog isoform X2
neuron-specific protein family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
neuron-specific protein family member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC110405541, transcript variant X1
uncharacterized LOC110405541, transcript variant X2
uncharacterized LOC110405334, transcript variant X4
uncharacterized LOC110405334, transcript variant X7
uncharacterized LOC110405334, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X2
uncharacterized LOC110405334, transcript variant X8
uncharacterized LOC110405334, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC110405334, transcript variant X11
uncharacterized LOC110405334, transcript variant X9
uncharacterized LOC110405335, transcript variant X2
uncharacterized LOC110405335, transcript variant X3
uncharacterized LOC110405335, transcript variant X1
uncharacterized LOC110405296, transcript variant X2
uncharacterized LOC110405296, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 81% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
dopamine receptor D1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
dopamine receptor D1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kinesin family member 20A, transcript variant X1
kinesin family member 20A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kinesin family member 20A, transcript variant X2
bromodomain containing 8, transcript variant X4
bromodomain containing 8, transcript variant X5
bromodomain containing 8, transcript variant X1
bromodomain containing 8, transcript variant X3
bromodomain containing 8, transcript variant X2
bromodomain containing 8, transcript variant X6
bromodomain containing 8, transcript variant X7
bromodomain containing 8, transcript variant X9
bromodomain containing 8, transcript variant X8
bromodomain-containing protein 8 isoform X2
bromodomain-containing protein 8 isoform X1
bromodomain-containing protein 8 isoform X3
bromodomain-containing protein 8 isoform X4
bromodomain-containing protein 8 isoform X5
bromodomain-containing protein 8 isoform X6
bromodomain-containing protein 8 isoform X7
bromodomain-containing protein 8 isoform X9
bromodomain-containing protein 8 isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01007175.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 83 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: added 47 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon.
vesicular integral-membrane protein VIP36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 34 member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 34 member 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
solute carrier family 34 member 1, transcript variant X3
solute carrier family 34 member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sodium-dependent phosphate transport protein 2A isoform X1
sodium-dependent phosphate transport protein 2A isoform X2
solute carrier family 34 member 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sodium-dependent phosphate transport protein 2A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor kinase 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
G protein-coupled receptor kinase 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
G protein-coupled receptor kinase 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
G protein-coupled receptor kinase 6 isoform X4
G protein-coupled receptor kinase 6 isoform X1
G protein-coupled receptor kinase 6 isoform X2
G protein-coupled receptor kinase 6, transcript variant X3
G protein-coupled receptor kinase 6 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X6
PDZ and LIM domain 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PDZ and LIM domain 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
PDZ and LIM domain 7, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
docking protein 3, transcript variant X2
docking protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX41
family with sequence similarity 193 member B, transcript variant X2
family with sequence similarity 193 member B, transcript variant X1
lateral signaling target protein 2 homolog, transcript variant X1
lateral signaling target protein 2 homolog, transcript variant X2
lateral signaling target protein 2 homolog isoform X1
lateral signaling target protein 2 homolog isoform X2
MAX dimerization protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
MAX dimerization protein 3, transcript variant X2
PRELI domain-containing protein 1, mitochondrial
nuclear receptor binding SET domain protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear receptor binding SET domain protein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
nuclear receptor binding SET domain protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific isoform X3
histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific isoform X1
fibroblast growth factor receptor 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
fibroblast growth factor receptor 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fibroblast growth factor receptor 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
fibroblast growth factor receptor 4 isoform X3
fibroblast growth factor receptor 4 isoform X2
fibroblast growth factor receptor 4 isoform X1
zinc finger protein 346, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
zinc finger protein 346, transcript variant X2
hexokinase-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hexokinase-3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hexokinase-3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hexokinase-3-like, transcript variant X4
hexokinase-3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
hexokinase-3-like, transcript variant X5
hexokinase-3-like, transcript variant X8
hexokinase-3-like, transcript variant X7
hexokinase-3-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E family member 1B
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
eukaryotic translation initiation factor 4E type 1B
G protein regulated inducer of neurite outgrowth 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 95% coverage of the annotated genomic feature by RNAseq alignments
G protein-regulated inducer of neurite outgrowth 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ring finger protein 44, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ring finger protein 44, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
ring finger protein 44, transcript variant X3
HIG1 hypoxia inducible domain family member 2A
HIG1 domain family member 2A, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SUMO interacting motifs containing 1, transcript variant X2
SUMO interacting motifs containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
SUMO interacting motifs containing 1, transcript variant X1
SUMO interacting motifs containing 1, transcript variant X4
SUMO-interacting motif-containing protein 1 isoform X1
SUMO-interacting motif-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic secretory trypsin inhibitor-like
uncharacterized LOC110405358, transcript variant X1
uncharacterized LOC110405358, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110405358, transcript variant X3
serine protease inhibitor Kazal-type 5-like
serine protease inhibitor Kazal-type 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
serine protease inhibitor Kazal-type 6-like isoform X3
serine protease inhibitor Kazal-type 6-like, transcript variant X1
serine protease inhibitor Kazal-type 6-like, transcript variant X2
serine protease inhibitor Kazal-type 4-like isoform X1
serine protease inhibitor Kazal-type 6-like isoform X2
ubiquitin like domain containing CTD phosphatase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin like domain containing CTD phosphatase 1, transcript variant X1
ubiquitin-like domain-containing CTD phosphatase 1
ring finger protein 145, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
ring finger protein 145, transcript variant X1
early B-cell factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
early B-cell factor 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
early B-cell factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
early B-cell factor 1, transcript variant X2
early B-cell factor 1, transcript variant X7
early B-cell factor 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
early B-cell factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
early B-cell factor 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
early B-cell factor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC110405215, transcript variant X4
uncharacterized LOC110405215, transcript variant X1
uncharacterized LOC110405215, transcript variant X3
uncharacterized LOC110405215, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
U7 snRNA-associated Sm-like protein LSm11
tRNA-histidine guanylyltransferase 1 like, transcript variant X1
tRNA-histidine guanylyltransferase 1 like, transcript variant X2
tRNA-histidine guanylyltransferase 1 like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
probable tRNA(His) guanylyltransferase isoform X1
probable tRNA(His) guanylyltransferase isoform X3
probable tRNA(His) guanylyltransferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADAM metallopeptidase domain 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ADAM metallopeptidase domain 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ADAM metallopeptidase domain 19, transcript variant X3
ADAM metallopeptidase domain 19, transcript variant X4
disintegrin and metalloproteinase domain-containing protein 19 isoform X3
disintegrin and metalloproteinase domain-containing protein 19 isoform X2
disintegrin and metalloproteinase domain-containing protein 19 isoform X1
NIPA like domain containing 4, transcript variant X2
NIPA like domain containing 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytoplasmic FMR1 interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytoplasmic FMR1-interacting protein 2 isoform X2
cytoplasmic FMR1-interacting protein 2 isoform X1
fibronectin type III domain containing 9
fibronectin type III domain-containing protein 9
mediator of RNA polymerase II transcription subunit 7
hepatitis A virus cellular receptor 2, transcript variant X8
hepatitis A virus cellular receptor 2, transcript variant X9
hepatitis A virus cellular receptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
hepatitis A virus cellular receptor 2, transcript variant X3
hepatitis A virus cellular receptor 2, transcript variant X4
hepatitis A virus cellular receptor 2, transcript variant X6
hepatitis A virus cellular receptor 2, transcript variant X7
hepatitis A virus cellular receptor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
hepatitis A virus cellular receptor 2, transcript variant X5
hepatitis A virus cellular receptor 2 isoform X1
hepatitis A virus cellular receptor 2 isoform X2
hepatitis A virus cellular receptor 2 isoform X4
hepatitis A virus cellular receptor 2 isoform X3
hepatitis A virus cellular receptor 2 isoform X5
hepatitis A virus cellular receptor 2 isoform X6
hepatitis A virus cellular receptor 2 isoform X7
hepatitis A virus cellular receptor 2 isoform X8
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X4
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X2
T-cell immunoglobulin and mucin domain-containing protein 4-like, transcript variant X3
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X4
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X1
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X2
T-cell immunoglobulin and mucin domain-containing protein 4-like isoform X3
sarcoglycan delta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sarcoglycan delta, transcript variant X9
sarcoglycan delta, transcript variant X2
sarcoglycan delta, transcript variant X8
sarcoglycan delta, transcript variant X1
sarcoglycan delta, transcript variant X6
sarcoglycan delta, transcript variant X4
sarcoglycan delta, transcript variant X7
sarcoglycan delta, transcript variant X5
sarcoglycan delta, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sarcoglycan delta, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sarcoglycan delta, transcript variant X12
mitochondrial ribosomal protein L22, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
mitochondrial ribosomal protein L22, transcript variant X7
mitochondrial ribosomal protein L22, transcript variant X3
mitochondrial ribosomal protein L22, transcript variant X6
39S ribosomal protein L22, mitochondrial
gem nuclear organelle associated protein 5, transcript variant X2
gem nuclear organelle associated protein 5, transcript variant X1
CCR4-NOT transcription complex subunit 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 8, transcript variant X2
CCR4-NOT transcription complex subunit 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 8
fatty acid hydroxylase domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
fatty acid hydroxylase domain containing 2, transcript variant X9
fatty acid hydroxylase domain containing 2, transcript variant X1
fatty acid hydroxylase domain containing 2, transcript variant X8
fatty acid hydroxylase domain containing 2, transcript variant X6
fatty acid hydroxylase domain containing 2, transcript variant X2
fatty acid hydroxylase domain containing 2, transcript variant X4
fatty acid hydroxylase domain containing 2, transcript variant X3
fatty acid hydroxylase domain containing 2, transcript variant X7
fatty acid hydroxylase domain-containing protein 2 isoform X2
fatty acid hydroxylase domain-containing protein 2 isoform X1
fatty acid hydroxylase domain-containing protein 2 isoform X3
fatty acid hydroxylase domain-containing protein 2 isoform X4
La ribonucleoprotein domain family member 1, transcript variant X1
La ribonucleoprotein domain family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
La ribonucleoprotein domain family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
La ribonucleoprotein domain family member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
heart and neural crest derivatives expressed 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
heart- and neural crest derivatives-expressed protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
histone deacetylase complex subunit SAP30L
polypeptide N-acetylgalactosaminyltransferase 10
microfibril associated protein 3, transcript variant X2
microfibril associated protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
microfibril associated protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
microfibril associated protein 3, transcript variant X1
microfibril associated protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X3
family with sequence similarity 114 member A2, transcript variant X2
family with sequence similarity 114 member A2, transcript variant X1
family with sequence similarity 114 member A2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
family with sequence similarity 114 member A2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
major centromere autoantigen B-like, transcript variant X1
major centromere autoantigen B-like, transcript variant X2
uncharacterized protein LOC110405228 isoform X1
major centromere autoantigen B-like isoform X2
LON peptidase N-terminal domain and RING finger protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC110405376, transcript variant X5
uncharacterized LOC110405376, transcript variant X4
uncharacterized LOC110405376, transcript variant X2
uncharacterized LOC110405376, transcript variant X1
uncharacterized LOC110405376, transcript variant X7
uncharacterized LOC110405376, transcript variant X3
uncharacterized LOC110405376, transcript variant X6
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 79 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 78 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate ionotropic receptor AMPA type subunit 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC110405336, transcript variant X2
uncharacterized LOC110405336, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110405145, transcript variant X1
uncharacterized LOC110405145, transcript variant X2
uncharacterized LOC110405145, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: glycine receptor subunit alpha-1
G3BP stress granule assembly factor 1, transcript variant X2
G3BP stress granule assembly factor 1, transcript variant X1
ras GTPase-activating protein-binding protein 1 isoform X2
ras GTPase-activating protein-binding protein 1 isoform X1
antioxidant 1 copper chaperone, transcript variant X2
copper transport protein ATOX1 isoform X2
antioxidant 1 copper chaperone, transcript variant X1
copper transport protein ATOX1 isoform X1
secreted protein acidic and cysteine rich
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
proton-coupled amino acid transporter 1-like, transcript variant X1
proton-coupled amino acid transporter 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
proton-coupled amino acid transporter 1-like
coiled-coil domain-containing protein 69
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
TNFAIP3 interacting protein 1, transcript variant X3
TNFAIP3 interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
TNFAIP3 interacting protein 1, transcript variant X4
TNFAIP3 interacting protein 1, transcript variant X2
TNFAIP3-interacting protein 1 isoform X1
TNFAIP3-interacting protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
dynactin subunit 4, transcript variant X1
dynactin subunit 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
N-deacetylase and N-sulfotransferase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
N-deacetylase and N-sulfotransferase 1, transcript variant X1
N-deacetylase and N-sulfotransferase 1, transcript variant X3
N-deacetylase and N-sulfotransferase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 isoform X3
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
HLA class II histocompatibility antigen gamma chain isoform X1
HLA class II histocompatibility antigen gamma chain isoform X2
HLA class II histocompatibility antigen gamma chain isoform X3
HLA class II histocompatibility antigen gamma chain isoform X4
treacle ribosome biogenesis factor 1, transcript variant X3
treacle ribosome biogenesis factor 1, transcript variant X2
treacle ribosome biogenesis factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC110405366, transcript variant X2
uncharacterized LOC110405366, transcript variant X3
uncharacterized LOC110405366, transcript variant X1
calcium/calmodulin dependent protein kinase II alpha, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin dependent protein kinase II alpha, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X1
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X2
calcium/calmodulin dependent protein kinase II alpha, transcript variant X3
calcium/calmodulin-dependent protein kinase type II subunit alpha isoform X3
solute carrier family 6 member 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 6 member 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium-dependent proline transporter isoform X2
sodium-dependent proline transporter isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
platelet derived growth factor receptor beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
platelet-derived growth factor receptor beta
macrophage colony-stimulating factor 1 receptor
HMG-box containing 3, transcript variant X2
HMG-box containing 3, transcript variant X1
HMG domain-containing protein 3 isoform X2
HMG domain-containing protein 3 isoform X1
neuropeptide Y receptor type 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
neuropeptide Y receptor type 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
neuropeptide Y receptor type 2-like isoform X1
neuropeptide Y receptor type 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
fms related tyrosine kinase 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
vascular endothelial growth factor receptor 3 isoform X3
fms related tyrosine kinase 4, transcript variant X2
fms related tyrosine kinase 4, transcript variant X1
vascular endothelial growth factor receptor 3 isoform X1
vascular endothelial growth factor receptor 3 isoform X2
ring finger protein 130, transcript variant X2
ring finger protein 130, transcript variant X1
E3 ubiquitin-protein ligase RNF130 isoform X2
E3 ubiquitin-protein ligase RNF130 isoform X1
MRN complex interacting protein, transcript variant X1
MRN complex interacting protein, transcript variant X2
MRN complex-interacting protein isoform X1
MRN complex-interacting protein isoform X2
uncharacterized LOC110405333, transcript variant X1
uncharacterized LOC110405333, transcript variant X2
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B, transcript variant X1
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X1
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X3
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B, transcript variant X2
alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B isoform X2
leukotriene C4 synthase-like, transcript variant X1
leukotriene C4 synthase-like, transcript variant X2
mastermind like transcriptional coactivator 1, transcript variant X2
mastermind like transcriptional coactivator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
leukotriene C4 synthase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
leukotriene C4 synthase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
leukotriene C4 synthase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H1, transcript variant X2
heterogeneous nuclear ribonucleoprotein H1, transcript variant X7
heterogeneous nuclear ribonucleoprotein H1, transcript variant X1
heterogeneous nuclear ribonucleoprotein H1, transcript variant X6
heterogeneous nuclear ribonucleoprotein H1, transcript variant X3
heterogeneous nuclear ribonucleoprotein H1, transcript variant X4
heterogeneous nuclear ribonucleoprotein H1, transcript variant X10
heterogeneous nuclear ribonucleoprotein H1, transcript variant X5
heterogeneous nuclear ribonucleoprotein H1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein H isoform X1
heterogeneous nuclear ribonucleoprotein H isoform X2
heterogeneous nuclear ribonucleoprotein H isoform X3
heterogeneous nuclear ribonucleoprotein H isoform X4
heterogeneous nuclear ribonucleoprotein H isoform X5
heterogeneous nuclear ribonucleoprotein H isoform X6
heterogeneous nuclear ribonucleoprotein H isoform X7
RUN and FYVE domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1 isoform X1
RUN and FYVE domain containing 1, transcript variant X2
RUN and FYVE domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
RUN and FYVE domain-containing protein 1 isoform X2
ADAM metallopeptidase with thrombospondin type 1 motif 2
A disintegrin and metalloproteinase with thrombospondin motifs 2
CCR4-NOT transcription complex subunit 6, transcript variant X3
CCR4-NOT transcription complex subunit 6, transcript variant X1
CCR4-NOT transcription complex subunit 6, transcript variant X2
CCR4-NOT transcription complex subunit 6 isoform X2
CCR4-NOT transcription complex subunit 6 isoform X1
glutamine-fructose-6-phosphate transaminase 2, transcript variant X1
glutamine-fructose-6-phosphate transaminase 2, transcript variant X3
glutamine-fructose-6-phosphate transaminase 2, transcript variant X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X1
glutamine-fructose-6-phosphate transaminase 2, transcript variant X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 isoform X2
mitogen-activated protein kinase 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
mitogen-activated protein kinase 9, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
mitogen-activated protein kinase 9 isoform X2
mitogen-activated protein kinase 9 isoform X1
mitogen-activated protein kinase 9 isoform X3
mitogen-activated protein kinase 9 isoform X4
uncharacterized LOC110405110, transcript variant X1
uncharacterized LOC110405110, transcript variant X2
RasGEF domain family member 1C, transcript variant X1
RasGEF domain family member 1C, transcript variant X2
ras-GEF domain-containing family member 1C isoform X1
RasGEF domain family member 1C, transcript variant X3
ras-GEF domain-containing family member 1C isoform X2
uncharacterized LOC110405161, transcript variant X2
uncharacterized LOC110405161, transcript variant X1
CDC like kinase 4, transcript variant X1
CDC like kinase 4, transcript variant X2
dual specificity protein kinase CLK4 isoform X1
CDC like kinase 4, transcript variant X3
dual specificity protein kinase CLK4 isoform X2
dual specificity protein kinase CLK4 isoform X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X8
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X4
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X1
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
5-phosphohydroxy-L-lysine phospho-lyase isoform X1
5-phosphohydroxy-L-lysine phospho-lyase isoform X2
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X7
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X3
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X6
heterogeneous nuclear ribonucleoprotein A/B, transcript variant X2
heterogeneous nuclear ribonucleoprotein A/B isoform X2
heterogeneous nuclear ribonucleoprotein A/B isoform X1
NME/NM23 family member 5, transcript variant X3
NME/NM23 family member 5, transcript variant X1
NME/NM23 family member 5, transcript variant X4
NME/NM23 family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
NME/NM23 family member 5, transcript variant X5
NME/NM23 family member 5, transcript variant X8
NME/NM23 family member 5, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
nucleoside diphosphate kinase homolog 5 isoform X1
nucleoside diphosphate kinase homolog 5 isoform X2
nucleoside diphosphate kinase homolog 5 isoform X4
nucleoside diphosphate kinase homolog 5 isoform X5
nucleoside diphosphate kinase homolog 5 isoform X3
NME/NM23 family member 5, transcript variant X6
NME/NM23 family member 5, transcript variant X9
NME/NM23 family member 5, transcript variant X10
nucleoside diphosphate kinase homolog 5 isoform X6
nucleoside diphosphate kinase homolog 5 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC110405463, transcript variant X1
uncharacterized LOC110405463, transcript variant X3
uncharacterized LOC110405463, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC110405465, transcript variant X1
uncharacterized LOC110405465, transcript variant X2
family with sequence similarity 13 member B, transcript variant X4
family with sequence similarity 13 member B, transcript variant X1
family with sequence similarity 13 member B, transcript variant X2
family with sequence similarity 13 member B, transcript variant X3
family with sequence similarity 13 member B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X1
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X3
polycystin 2 like 2, transient receptor potential cation channel, transcript variant X2
polycystic kidney disease 2-like 2 protein isoform X1
polycystic kidney disease 2-like 2 protein isoform X2
polycystic kidney disease 2-like 2 protein isoform X3
polycystic kidney disease 2-like 2 protein isoform X4
uncharacterized LOC110405461, transcript variant X1
uncharacterized LOC110405461, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
heterogeneous nuclear ribonucleoprotein A0
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
kelch like family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
kelch like family member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
kelch like family member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
kelch like family member 3, transcript variant X4
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1, transcript variant X1
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1, transcript variant X3
SPARC/osteonectin, cwcv and kazal like domains proteoglycan 1, transcript variant X2
transient receptor potential cation channel subfamily C member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
short transient receptor potential channel 7
uncharacterized LOC110405262, transcript variant X2
uncharacterized LOC110405262, transcript variant X1
uncharacterized protein LOC110405262 isoform X2
uncharacterized protein LOC110405262 isoform X1
SMAD family member 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
SMAD family member 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
SMAD family member 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
SMAD family member 5, transcript variant X4
mothers against decapentaplegic homolog 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
transforming growth factor-beta-induced protein ig-h3
uncharacterized LOC110405242, transcript variant X2
uncharacterized LOC110405242, transcript variant X3
uncharacterized LOC110405242, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
F-box and leucine rich repeat protein 21, transcript variant X3
F-box and leucine rich repeat protein 21, transcript variant X1
F-box and leucine rich repeat protein 21, transcript variant X2
solute carrier family 25 member 48, transcript variant X2
solute carrier family 25 member 48, transcript variant X1
uncharacterized LOC110405447, transcript variant X3
uncharacterized LOC110405447, transcript variant X4
uncharacterized LOC110405447, transcript variant X1
uncharacterized LOC110405447, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
core histone macro-H2A.1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
core histone macro-H2A.1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
uncharacterized LOC110405166, transcript variant X4
uncharacterized LOC110405166, transcript variant X3
uncharacterized LOC110405166, transcript variant X2
uncharacterized LOC110405166, transcript variant X1
uncharacterized LOC110405395, transcript variant X1
uncharacterized LOC110405395, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
cation channel sperm associated 3, transcript variant X3
cation channel sperm associated 3, transcript variant X1
cation channel sperm associated 3, transcript variant X2
cation channel sperm-associated protein 3
pterin-4 alpha-carbinolamine dehydratase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
pterin-4-alpha-carbinolamine dehydratase 2
thioredoxin domain-containing protein 15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
probable ATP-dependent RNA helicase DDX46
calcium signal-modulating cyclophilin ligand
SEC24 homolog A, COPII coat complex component
secretion associated Ras related GTPase 1B, transcript variant X1
secretion associated Ras related GTPase 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
similar to RNA sequence (same species):INSD:GBYG01027841.1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: added 106 bases not found in genome assembly; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ubiquitin conjugating enzyme E2 B, transcript variant X4
ubiquitin conjugating enzyme E2 B, transcript variant X3
ubiquitin conjugating enzyme E2 B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 B isoform X1
ubiquitin-conjugating enzyme E2 B isoform X3
ubiquitin conjugating enzyme E2 B, transcript variant X2
ubiquitin-conjugating enzyme E2 B isoform X2
protein phosphatase 2 catalytic subunit alpha
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 67 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform
uncharacterized LOC110405292, transcript variant X6
uncharacterized LOC110405292, transcript variant X4
uncharacterized LOC110405292, transcript variant X3
uncharacterized LOC110405292, transcript variant X5
uncharacterized LOC110405292, transcript variant X1
uncharacterized LOC110405292, transcript variant X2
transcription factor 7, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcription factor 7, transcript variant X3
transcription factor 7, transcript variant X1
transcription factor 7, transcript variant X5
transcription factor 7, transcript variant X2
transcription factor 7, transcript variant X4
uncharacterized LOC110405518, transcript variant X3
uncharacterized LOC110405518, transcript variant X2
uncharacterized LOC110405518, transcript variant X1
voltage dependent anion channel 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
voltage dependent anion channel 1, transcript variant X1
voltage-dependent anion-selective channel protein 1
keratinocyte-associated transmembrane protein 2
follistatin like 4, transcript variant X1
follistatin-related protein 4 isoform X1
follistatin like 4, transcript variant X2
follistatin-related protein 4 isoform X2
Rap guanine nucleotide exchange factor 6, transcript variant X4
Rap guanine nucleotide exchange factor 6, transcript variant X2
Rap guanine nucleotide exchange factor 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Rap guanine nucleotide exchange factor 6, transcript variant X6
Rap guanine nucleotide exchange factor 6, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rap guanine nucleotide exchange factor 6, transcript variant X1
Rap guanine nucleotide exchange factor 6, transcript variant X3
rap guanine nucleotide exchange factor 6 isoform X4
rap guanine nucleotide exchange factor 6 isoform X2
rap guanine nucleotide exchange factor 6 isoform X7
rap guanine nucleotide exchange factor 6 isoform X3
rap guanine nucleotide exchange factor 6 isoform X6
rap guanine nucleotide exchange factor 6 isoform X1
rap guanine nucleotide exchange factor 6 isoform X5
folliculin interacting protein 1, transcript variant X3
folliculin interacting protein 1, transcript variant X1
folliculin interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
folliculin-interacting protein 1 isoform X3
folliculin-interacting protein 1 isoform X1
folliculin-interacting protein 1 isoform X2
acyl-CoA synthetase long-chain family member 6, transcript variant X1
acyl-CoA synthetase long-chain family member 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA synthetase long-chain family member 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
acyl-CoA synthetase long-chain family member 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acyl-CoA synthetase long-chain family member 6, transcript variant X3
long-chain-fatty-acid--CoA ligase 6 isoform X1
long-chain-fatty-acid--CoA ligase 6 isoform X2
long-chain-fatty-acid--CoA ligase 6 isoform X3
prolyl 4-hydroxylase subunit alpha 2, transcript variant X1
prolyl 4-hydroxylase subunit alpha 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
prolyl 4-hydroxylase subunit alpha 2, transcript variant X4
prolyl 4-hydroxylase subunit alpha 2, transcript variant X3
prolyl 4-hydroxylase subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2 isoform X3
prolyl 4-hydroxylase subunit alpha-2 isoform X1
prolyl 4-hydroxylase subunit alpha-2 isoform X2
prolyl 4-hydroxylase subunit alpha-2 isoform X5
prolyl 4-hydroxylase subunit alpha 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
prolyl 4-hydroxylase subunit alpha-2 isoform X4
solute carrier family 22 member 4-like, transcript variant X1
solute carrier family 22 member 4-like, transcript variant X3
solute carrier family 22 member 4-like, transcript variant X2
solute carrier family 22 member 5-like isoform X1
solute carrier family 22 member 5-like isoform X2
solute carrier family 22 member 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
interferon regulatory factor 1, transcript variant X1
interferon regulatory factor 1, transcript variant X2
RAD50 double strand break repair protein, transcript variant X1
RAD50 double strand break repair protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 34% coverage of the annotated genomic feature by RNAseq alignments
kinesin family member 3A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
kinesin family member 3A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
cyclin I family member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
cyclin I family member 2, transcript variant X1
cyclin I family member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cyclin I family member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
shroom family member 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
shroom family member 1, transcript variant X11
sosondowah ankyrin repeat domain family member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat domain-containing protein SOWAHA
shroom family member 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
shroom family member 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
shroom family member 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
shroom family member 1, transcript variant X5
shroom family member 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
shroom family member 1, transcript variant X8
shroom family member 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
shroom family member 1, transcript variant X9
shroom family member 1, transcript variant X1
shroom family member 1, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
AF4/FMR2 family member 4, transcript variant X5
zinc finger CCHC domain-containing protein 10
heat shock protein family A (Hsp70) member 4, transcript variant X1
heat shock protein family A (Hsp70) member 4, transcript variant X2
ring finger protein 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ring finger protein 14, transcript variant X1
ring finger protein 14, transcript variant X2
E3 ubiquitin-protein ligase RNF14 isoform X1
ring finger protein 14, transcript variant X4
E3 ubiquitin-protein ligase RNF14 isoform X2
Nedd4 family interacting protein 1, transcript variant X2
Nedd4 family interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fibroblast growth factor 1, transcript variant X2
fibroblast growth factor 1, transcript variant X4
Rho GTPase activating protein 26, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X1
Rho GTPase activating protein 26, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X4
Rho GTPase activating protein 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
rho GTPase-activating protein 26 isoform X2
Rho GTPase activating protein 26, transcript variant X3
rho GTPase-activating protein 26 isoform X3
nuclear receptor subfamily 3 group C member 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC110405398, transcript variant X1
uncharacterized LOC110405398, transcript variant X2
potassium channel tetramerization domain containing 16, transcript variant X3
potassium channel tetramerization domain containing 16, transcript variant X4
potassium channel tetramerization domain containing 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
potassium channel tetramerization domain containing 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD16
uncharacterized LOC110405431, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC110405431, transcript variant X1
glutaredoxin and cysteine rich domain containing 2, transcript variant X3
glutaredoxin and cysteine rich domain containing 2, transcript variant X2
glutaredoxin and cysteine rich domain containing 2, transcript variant X1
glutaredoxin domain-containing cysteine-rich protein 2 isoform X1
glutaredoxin and cysteine rich domain containing 2, transcript variant X4
glutaredoxin domain-containing cysteine-rich protein 2 isoform X2
SH3 domain containing ring finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
SH3 domain containing ring finger 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
SH3 domain containing ring finger 2, transcript variant X4
SH3 domain containing ring finger 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
SH3 domain containing ring finger 2, transcript variant X2
SH3 domain containing ring finger 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
putative E3 ubiquitin-protein ligase SH3RF2 isoform X1
putative E3 ubiquitin-protein ligase SH3RF2 isoform X2
putative E3 ubiquitin-protein ligase SH3RF2 isoform X3
putative E3 ubiquitin-protein ligase SH3RF2 isoform X4
leucyl-tRNA synthetase, transcript variant X1
leucine--tRNA ligase, cytoplasmic isoform X1
leucyl-tRNA synthetase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
leucine--tRNA ligase, cytoplasmic isoform X2
RNA binding motif protein 27, transcript variant X3
RNA binding motif protein 27, transcript variant X1
RNA binding motif protein 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
POU domain, class 4, transcription factor 3
transcription elongation regulator 1, transcript variant X1
transcription elongation regulator 1, transcript variant X2
transcription elongation regulator 1, transcript variant X3
transcription elongation regulator 1, transcript variant X4
transcription elongation regulator 1 isoform X1
transcription elongation regulator 1 isoform X2
transcription elongation regulator 1 isoform X3
transcription elongation regulator 1 isoform X4
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protein phosphatase 2 regulatory subunit Bbeta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X2
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X1
serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform isoform X3
uncharacterized LOC110405483, transcript variant X1
uncharacterized LOC110405483, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
janus kinase and microtubule interacting protein 2, transcript variant X1
janus kinase and microtubule interacting protein 2, transcript variant X3
janus kinase and microtubule interacting protein 2, transcript variant X2
janus kinase and microtubule interacting protein 2, transcript variant X4
janus kinase and microtubule-interacting protein 2 isoform X1
janus kinase and microtubule interacting protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
janus kinase and microtubule-interacting protein 2 isoform X2
cell division cycle 23, transcript variant X1
cell division cycle 23, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
cell division cycle protein 23 homolog isoform X1
cell division cycle protein 23 homolog isoform X2
uncharacterized LOC110405199, transcript variant X2
uncharacterized LOC110405199, transcript variant X3
uncharacterized LOC110405199, transcript variant X4
uncharacterized LOC110405199, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
C-terminal-binding protein 2, transcript variant X2
C-terminal-binding protein 2, transcript variant X1
lysine demethylase 3B, transcript variant X1
lysine demethylase 3B, transcript variant X2
lysine-specific demethylase 3B isoform X1
lysine-specific demethylase 3B isoform X2
receptor accessory protein 2, transcript variant X4
receptor accessory protein 2, transcript variant X1
receptor accessory protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
receptor expression-enhancing protein 2 isoform X1
receptor expression-enhancing protein 2 isoform X2
receptor accessory protein 2, transcript variant X3
receptor expression-enhancing protein 2 isoform X3